Pregnancy is a diabetogenic state due to rise of anti insulin hormones like human placental lactogen, steroids, progesterone and glucagon. In pregnancy normal values for fasting blood sugar level and post meal blood sugar level are less than normal population by approximately 10-20 mg/dl. Universal screening is advocated for all women at 24/28 weeks. Those with high risks should be screened at initial visit and then at 24/28 weeks. Diagnostic values have changed over period of time. Pregestational diabetic patients should ideally be on insulin therapy before planning pregnancy. Long term follow up of gestational diabetes mellitus patients is must. This patient should undergo glucose tolerance test after 6 weeks of delivery and once in a year thereafter. Management of diabetes mellitus in pregnancy is a team approach.
In future there is going to be marked increase in the cases of diabetes in pregnancy. This is because of phenomenal increase in diabetic incidence and prevalence not only in middle age but also in the child bearing age group of 25 to 40. At present 8-12% of urban and as well rural population of India is having diabetes [1] [2] [3] [4] [5] . With tendency towards late marriages and planning for a baby at later age, number of diabetic pregnancies will rise. With in vitro fertilization (IVF) facilities and use of progestational drugs this number will increase further 6 .
Pathophysiology
Pregnancy is a diabetogenic state. Those who are predisposed to develop diabetes mellitus (DM) in future for genetic reasons, family history of DM coupled with obesity will likely to have impaired glucoses intolerance or frank DM in pregnancy. This is because of rise of anti insulin hormones like human placental lactogen, steroids, progesterone and glucagon. Rise in free fatty acids and tumour necrosis factor alfa (TNF α) also contribute to insulin resistance 7 . Those who cannot produce adequate insulin to counter these changes will develop DM. Types of DM in pregnancy DM can predate pregnancy. This is known as pregestational diabetes. Most cases belong to Type 2 D.M. But there is also a steady increase in Type 1 DM. When DM is detected or diagnosed for the first time in pregnancy (usually in predisposed individuals and at 24-28 weeks), it is termed as gestational diabetes mellitus (GDM) Usually it is type 2 or Non-Insulin Dependent DM. Rarely Type 1 DM can declare itself 5 during pregnancy. The basic difference between pre gestational and gestational DM is for the neonatal outcome. If blood sugar level (BSL) are not well controlled in the first trimester, there are chances of congenital malformation (6-11%) in pregestational DM and which are virtually non-existent in gestational diabetes [8] [9] [10] . This is because of teratogenic effects of high blood sugar on baby if BSL are not well controlled in first trimester. Other neonatal outcomes like macrosomia, other complications and as well maternal outcomes are same in both types if BSL not well controlled 11 . Normal pregnancy with normal BSL can have congenital malformation in 2 % of pregnancies.
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Gestational Diabetes Mellitus (GDM)
GDM is a glucose intolerant state with onset or first recognition during pregnancy 13 . It includes clinically undetected Type 2 and rarely Type1 DM. Its incidence: 14 . There is increasing incidence in India, around 0.56% -6% according to study by Ramachandran A et al. 5 In USA the incidence ranges from 6 -7 % and recently there has been a significant increase in all racial/ethnic groups. Native Americans, Asian Africans, Hispanics are at higher risk (Ferrara, 2007) 15 . It is associated with risk to the mother in short term and long term. Short term risk includes increased incidence of caesarian section up to 30%, polyhydramnios in 20%, preeclampsia in 20-30% and preterm labor. The gestational diabetes may recur in subsequent pregnancy and these patients are more prone for future development of diabetes mellitus. There is also risk to the baby. There are chances of unexplained still birth similar to Pre GDM. Other risks include fetal macrosomia (> 4 Kg in weight), hypocalcaemia, hypoglycemia, jaundice, hyperviscosity, polycythemia, respiratory distress syndrome, cervical dystocia 16 Patient should further be followed with FBS and PMBSL at least biweekly (at times daily). If FBS is more than 90 mg/dl and PMBSL is more than 120 mg/dl then one needs start insulin therapy. This is between FBS and macrosomia. Table 5 shows the relationship between tight glycaemic control and the incidence of macrosomia. Management It includes medical nutritional therapy and insulin therapy. Calorie recommendation depends upon present weight and level of physical activity. Medical nutrition therapy is summarised in table 6. Sweeteners are not allowed during pregnancy. Although glibenclamide and metformin were used under trial conditions, they should be avoided. Initially diabetic diet trial for 3 /7 days in mild gestational DM patients is advocated. Insulin therapy should be started if BSL are not under control (If FBS > 90 mg/dl and PMBSL > 120 mg/dl). Diabetic mothers should be asked to keep BSL diary. They should do at least FBS, PMBSL, before dinner BSL and RBS (whenever patients feel the BSL are low or may be high) at least alternate day or biweekly. At times we require more frequent and daily monitoring especially in pregestational DM In certain uncontrolled GDM patients with high risk insulin analogues which can be used in pregnancy 22 . Decision about timing of delivery should be best left with the obstetrician. DM is not an indication of caesarean section. It should be carried out for obstetric reasons. Glucose, potassium, insulin drip should be used during labour if labour is prolonged and RBS is more than 120 mg/dl. Some patients require betamethasone therapy for fetal lung maturation. This often leads to elevation in blood sugar levels. During this period, frequent monitoring of blood glucose levels and escalation of insulin dosages (double/triple) will be needed. Table 8 summarises the management at the time of delivery. Long term follow up of GDM patients is must. This patient should undergo GTT after 6 weeks of delivery and once in a year thereafter 7 . Life style modifications should continue for life time as 30-50% of GDM patients have chance of development of frank DM in next 10 years. Management of DM in pregnancy is a team approach. Close liaison between patient, obstetrician and physician is must for better outcome for the baby and as well as to the mother.
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